Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

The trial against EpiPen settled; Viatris to pay $264 million

Viatris Inc, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class-action lawsuit alleging...

GSK halts phase III vaccine trial of respiratory virus in pregnant women

GlaxoSmithKline, a science-led global healthcare company, on Monday announced that the Company has decided to stop enrolment and vaccination in trials evaluating its potential...

Arbutus files patent infringement lawsuit against Moderna

Arbutus Biopharma Corporation and Genevant Sciences today filed a lawsuit in the U.S. District Court for the District of Delaware against Moderna, Inc. and...

Petrovax pharmaceutical company received a patent for Longidase® in South Korea

Petrovax has received a patent for the original medicine product Longidaza®, which is valid in South Korea protecting. During the COVID-19 pandemic, the drug product...

EMA – New medicine for rare type of eye cancer

EMA has recommended granting a marketing authorisation in the European Union (EU) for Kimmtrak (tebentafusp), a monotherapy for the treatment of adult patients with...

FDA limits use of GlaxoSmithKline and Vir’s COVID-19 antibody treatment in some geographic areas

The United States Food and Drug Administration stated GlaxoSmithKline and Vir Biotech's COVID-19 antibody treatment should not be used in places with circulation...
spot_img

Expert Articles

spot_img